Apr 23, 2025 08:00AM
Apr 10, 2025 08:00AM
Feb 27, 2025 08:00AM
Feb 19, 2025 08:00AM
Jan 22, 2025 08:00AM
Dec 10, 2024 08:00AM
Nov 27, 2024 08:00AM Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
Nov 12, 2024 08:00AM
Nov 6, 2024 08:00AM
Oct 31, 2024 08:00AM
Oct 10, 2024 08:00AM
Aug 6, 2024 08:00AM
Jul 16, 2024 08:00AM
Jul 10, 2024 08:00AM Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against WHO Priority Pathogen Acinetobacter baumannii
Jul 1, 2024 08:00AM
Jun 25, 2024 08:00AM
Jun 20, 2024 08:00AM
Jun 12, 2024 08:00AM
May 17, 2024 08:00AM
May 13, 2024 08:00AM
Apr 30, 2024 08:00AM Recce Pharmaceuticals Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
Apr 17, 2024 08:00AM
Apr 10, 2024 08:00AM
Apr 9, 2024 08:00PM
Apr 4, 2024 08:00AM
Mar 22, 2024 08:00AM
Mar 19, 2024 08:00AM
Mar 14, 2024 08:00AM Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
Mar 13, 2024 08:00AM
Mar 12, 2024 08:00AM
Feb 29, 2024 08:00AM
Feb 27, 2024 08:00AM
Feb 7, 2024 08:00AM
Jan 23, 2024 08:00AM
Dec 19, 2023 08:00AM Recce Pharmaceuticals Awarded AusIndustry Advanced Overseas Finding for Synthetic Anti-Infective Research & Development Program
Dec 18, 2023 08:00AM
Nov 27, 2023 08:00AM
Nov 9, 2023 08:00AM
Oct 25, 2023 08:00AM
Oct 3, 2023 08:00AM
Sep 26, 2023 08:00AM
Sep 13, 2023 08:00AM Recce Pharmaceuticals Secures $8M Placement and Launches $3M Entitlement Offer to Shareholders
Sep 7, 2023 08:00AM
Sep 1, 2023 08:00AM
Aug 29, 2023 08:00AM
Aug 24, 2023 08:00AM
Aug 23, 2023 08:00AM
Aug 10, 2023 08:00AM
Aug 4, 2023 08:00AM Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives
Aug 2, 2023 08:00AM

325,844 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All